Vijay Dhondge has more than 22 years of experience in Medicinal Chemistry, CDMO and Operations. He has a key expertise in Drug Discovery, Process Research, Product Development and Technology Transfer and cGMP Manufacturing. He co-authored over 20 publications, patents and articles. He developed IND molecule in antibacterial area-oxazolidinone, Fluoroquinolones and Efflux.

Vijay D. Dhondge Senior VP, CRO, CDMO and Operations

×

Speak With Expert

LAXAI supports customers achieve their Goals by strong emphasis on Safety, Quality, Reliability, Innovation and Efficiency by combining World Class Research Talent and Infrastructure with Cost Advantage.